Observational study of 18,000 patients finds 36% lower risk of
premature death.
For patients with Afib and Type 2 diabetes, GLP-1 drugs outperform SGLT-2 drugs
Home Top Stories Around Our Network For patients with Afib and Type 2 diabetes, GLP-1 drugs outperform SGLT-2 drugs